Inhibrx Biosciences Files to Sell 2.45M Shares of Common Stock for Holders
Inhibrx Biosciences(INBX.US) Director Buys US$997.02K in Common Stock
$Inhibrx Biosciences(INBX.US)$ Director Kayyem Jon Faiz purchased 57,549 shares of common stock on Jun 5, 2024 at an average price of $17.32 for a total value of $997.02K.Source: Announcement What is
Inhibrx Biosciences 13G Filing Shows Viking Global Investors LP Reported A 12.3% Stake In The Co As Of May 29, 2024
Inhibrx Biosciences 13G Filing Shows Viking Global Investors LP Reported A 12.3% Stake In The Co As Of May 29, 2024
Express News | Viking Global Investors LP Reports 12.3% Passive Stake in Inhibrx Biosciences, Inc. as of May 29, 2024- SEC Filing
Top 4 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing
Jon Faiz Kayyem, Director, on May 31, 2024, executed a purchase for 286,786 shares in Inhibrx Biosciences (INBX) for $4,927,580. Following the Form 4 filing with the SEC, Kayyem has control over a tot
Trading Halt: Halt Status Updated at 8:40:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 8:40:00 AM ET: Quotation Resumption: News and Resumption Times
Inhibrx Biosciences Announces Major Corporate Restructuring Events
News On Inhibrx Biosciences Inc. (INXBV) Now Under INXB
News On Inhibrx Biosciences Inc. (INXBV) Now Under INXB
No Data